Etibo 250mg Tablet

Dosage Form and Strength:

Film coated tablet. Each tablet contains Lapatinib Ditosylate (as monohydrate) IP equivalent to Lapatinib 250mg.

Mechanism of Action:

Tyrosine kinase inhibitor. Blocks abnormal protein signaling in cancer cells to prevent multiplication and slow spread of cancer.

Administration:

Oral use only. Take as directed by physician. Do not self-medicate.

Therapeutic Use:

Treatment of breast cancer, alone or in combination with chemotherapy. Relieves symptoms such as breast lumps, nipple discharge, or breast texture changes.

Usage Instruction:

Take on empty stomach or 1 hour before / 2 hours after meal. Swallow whole. Do not crush or chew. Keep out of reach of children.

Side Effects:

• Nausea, Vomiting, Abdominal pain, Back pain
• Constipation, Cough, Diarrhoea, Headache
• Fatigue, Weakness, Itching, Rash

Safety Precautions:

Alcohol: Consult doctor.
Pregnancy: Unsafe; may harm unborn baby.
Lactation: Unsafe; consult doctor.
Driving: May affect ability to drive.
Renal/Hepatic Impairment: Use with caution; consult doctor.

Contraindications:

• Known hypersensitivity

About Globeq

Globeq Healthcare Pharma Pvt. Ltd. is a leading SGS Compliance Wholesaler, Exporter, Distributor, and Supplier of Etibo 250mg Tablet. We ensure reliable and authentic pharmaceutical products across India and worldwide.